Perhaps this info has been supplied in earlier years, but I am interested in detail on the IP. I presume the 1A technology is protected by patents - when do they expire and/or can they be updated through tweaks etc. What other patents underpin the other products.
Also, its not obvious what other personnel they have with specialised knowledge and understanding of 1A. Is it just Rob, because if so perhaps he spreads himself too thinly dealing with the other aspects of the business. Perhaps they employ engineers in Sydney but I can't really tell.
I see there's a webinar on soon for Sepsis Alliance (thanks Niloony for link!) based in US on new guidelines for paediatric sepsis sponsored by UCM. Can he give us info on increased interest in 1A as a result of inclusion in guidelines.?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.759M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500000 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 46000 | 1 |
View Market Depth
| Last trade - 16.21pm 27/06/2025 (20 minute delay) ? |
| UCM (ASX) Chart |
Day chart unavailable